nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—SLC22A3—Metformin—polycystic ovary syndrome	0.275	0.475	CbGbCtD
Lamivudine—SLC22A2—Metformin—polycystic ovary syndrome	0.163	0.281	CbGbCtD
Lamivudine—SLC22A1—Metformin—polycystic ovary syndrome	0.141	0.244	CbGbCtD
Lamivudine—PGK1—uterus—polycystic ovary syndrome	0.00531	0.0368	CbGeAlD
Lamivudine—PCYT2—endocrine gland—polycystic ovary syndrome	0.0047	0.0326	CbGeAlD
Lamivudine—NT5C—uterus—polycystic ovary syndrome	0.00449	0.0311	CbGeAlD
Lamivudine—Gemcitabine—RRM2—polycystic ovary syndrome	0.00445	1	CrCbGaD
Lamivudine—NT5C—pituitary gland—polycystic ovary syndrome	0.00441	0.0305	CbGeAlD
Lamivudine—NT5C—adipose tissue—polycystic ovary syndrome	0.00439	0.0304	CbGeAlD
Lamivudine—Acidosis—Metformin—polycystic ovary syndrome	0.00431	0.0525	CcSEcCtD
Lamivudine—PGK1—endocrine gland—polycystic ovary syndrome	0.00404	0.028	CbGeAlD
Lamivudine—NT5C—adrenal gland—polycystic ovary syndrome	0.00394	0.0273	CbGeAlD
Lamivudine—NME2—embryo—polycystic ovary syndrome	0.00393	0.0272	CbGeAlD
Lamivudine—NME1-NME2—endocrine gland—polycystic ovary syndrome	0.00368	0.0255	CbGeAlD
Lamivudine—NT5C—female gonad—polycystic ovary syndrome	0.00367	0.0254	CbGeAlD
Lamivudine—NT5C—vagina—polycystic ovary syndrome	0.00365	0.0253	CbGeAlD
Lamivudine—NT5C—endocrine gland—polycystic ovary syndrome	0.00341	0.0236	CbGeAlD
Lamivudine—PCYT1A—endocrine gland—polycystic ovary syndrome	0.0032	0.0222	CbGeAlD
Lamivudine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00294	0.0359	CcSEcCtD
Lamivudine—Blood disorder—Metformin—polycystic ovary syndrome	0.00285	0.0348	CcSEcCtD
Lamivudine—NME1—uterus—polycystic ovary syndrome	0.00281	0.0195	CbGeAlD
Lamivudine—NME1—adipose tissue—polycystic ovary syndrome	0.00275	0.0191	CbGeAlD
Lamivudine—CMPK1—uterus—polycystic ovary syndrome	0.00271	0.0188	CbGeAlD
Lamivudine—CMPK1—pituitary gland—polycystic ovary syndrome	0.00266	0.0185	CbGeAlD
Lamivudine—CMPK1—adipose tissue—polycystic ovary syndrome	0.00265	0.0184	CbGeAlD
Lamivudine—NME2—adipose tissue—polycystic ovary syndrome	0.00259	0.018	CbGeAlD
Lamivudine—NME1—adrenal gland—polycystic ovary syndrome	0.00247	0.0171	CbGeAlD
Lamivudine—CMPK1—adrenal gland—polycystic ovary syndrome	0.00238	0.0165	CbGeAlD
Lamivudine—NME2—adrenal gland—polycystic ovary syndrome	0.00233	0.0161	CbGeAlD
Lamivudine—NME1—female gonad—polycystic ovary syndrome	0.0023	0.0159	CbGeAlD
Lamivudine—Neuropathy—Metformin—polycystic ovary syndrome	0.00224	0.0273	CcSEcCtD
Lamivudine—CMPK1—female gonad—polycystic ovary syndrome	0.00222	0.0154	CbGeAlD
Lamivudine—CMPK1—vagina—polycystic ovary syndrome	0.00221	0.0153	CbGeAlD
Lamivudine—NME2—female gonad—polycystic ovary syndrome	0.00217	0.015	CbGeAlD
Lamivudine—NME1—endocrine gland—polycystic ovary syndrome	0.00214	0.0148	CbGeAlD
Lamivudine—CMPK1—endocrine gland—polycystic ovary syndrome	0.00206	0.0143	CbGeAlD
Lamivudine—NME2—endocrine gland—polycystic ovary syndrome	0.00202	0.014	CbGeAlD
Lamivudine—DCK—embryo—polycystic ovary syndrome	0.002	0.0139	CbGeAlD
Lamivudine—Injury—Metformin—polycystic ovary syndrome	0.00188	0.0229	CcSEcCtD
Lamivudine—Renal impairment—Metformin—polycystic ovary syndrome	0.00182	0.0222	CcSEcCtD
Lamivudine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00177	0.0216	CcSEcCtD
Lamivudine—Migraine—Metformin—polycystic ovary syndrome	0.0017	0.0208	CcSEcCtD
Lamivudine—DCK—adrenal cortex—polycystic ovary syndrome	0.00164	0.0114	CbGeAlD
Lamivudine—SLC22A3—embryo—polycystic ovary syndrome	0.00163	0.0113	CbGeAlD
Lamivudine—Dehydration—Metformin—polycystic ovary syndrome	0.00161	0.0196	CcSEcCtD
Lamivudine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0016	0.0195	CcSEcCtD
Lamivudine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00158	0.0193	CcSEcCtD
Lamivudine—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00157	0.0109	CbGeAlD
Lamivudine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00156	0.019	CcSEcCtD
Lamivudine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00155	0.0189	CcSEcCtD
Lamivudine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00151	0.0183	CcSEcCtD
Lamivudine—Influenza—Metformin—polycystic ovary syndrome	0.0015	0.0182	CcSEcCtD
Lamivudine—Pancreatitis—Metformin—polycystic ovary syndrome	0.00147	0.0179	CcSEcCtD
Lamivudine—DCK—endometrium—polycystic ovary syndrome	0.00147	0.0102	CbGeAlD
Lamivudine—Sweating increased—Metformin—polycystic ovary syndrome	0.00146	0.0178	CcSEcCtD
Lamivudine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00143	0.0175	CcSEcCtD
Lamivudine—Neutropenia—Metformin—polycystic ovary syndrome	0.0014	0.017	CcSEcCtD
Lamivudine—DCK—uterus—polycystic ovary syndrome	0.00135	0.00936	CbGeAlD
Lamivudine—DCK—pituitary gland—polycystic ovary syndrome	0.00133	0.00919	CbGeAlD
Lamivudine—DCK—adipose tissue—polycystic ovary syndrome	0.00132	0.00915	CbGeAlD
Lamivudine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00131	0.0159	CcSEcCtD
Lamivudine—ABCC3—adipose tissue—polycystic ovary syndrome	0.00126	0.00876	CbGeAlD
Lamivudine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00126	0.0154	CcSEcCtD
Lamivudine—Rhinitis—Metformin—polycystic ovary syndrome	0.0012	0.0146	CcSEcCtD
Lamivudine—Hepatitis—Metformin—polycystic ovary syndrome	0.0012	0.0146	CcSEcCtD
Lamivudine—SLC22A3—endometrium—polycystic ovary syndrome	0.00119	0.00828	CbGeAlD
Lamivudine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00119	0.0145	CcSEcCtD
Lamivudine—DCK—adrenal gland—polycystic ovary syndrome	0.00118	0.00821	CbGeAlD
Lamivudine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00118	0.0143	CcSEcCtD
Lamivudine—ABCC3—adrenal gland—polycystic ovary syndrome	0.00113	0.00786	CbGeAlD
Lamivudine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00113	0.0078	CbGeAlD
Lamivudine—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00111	0.00766	CbGeAlD
Lamivudine—DCK—female gonad—polycystic ovary syndrome	0.0011	0.00765	CbGeAlD
Lamivudine—DCK—vagina—polycystic ovary syndrome	0.0011	0.00761	CbGeAlD
Lamivudine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00108	0.0132	CcSEcCtD
Lamivudine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00108	0.0131	CcSEcCtD
Lamivudine—SLC22A3—adipose tissue—polycystic ovary syndrome	0.00108	0.00746	CbGeAlD
Lamivudine—Chills—Metformin—polycystic ovary syndrome	0.00107	0.0131	CcSEcCtD
Lamivudine—ABCC4—uterus—polycystic ovary syndrome	0.00107	0.00739	CbGeAlD
Lamivudine—ABCC3—female gonad—polycystic ovary syndrome	0.00106	0.00733	CbGeAlD
Lamivudine—ABCC4—adipose tissue—polycystic ovary syndrome	0.00104	0.00723	CbGeAlD
Lamivudine—Erythema—Metformin—polycystic ovary syndrome	0.00104	0.0127	CcSEcCtD
Lamivudine—Malnutrition—Metformin—polycystic ovary syndrome	0.00104	0.0127	CcSEcCtD
Lamivudine—DCK—endocrine gland—polycystic ovary syndrome	0.00103	0.00712	CbGeAlD
Lamivudine—Flatulence—Metformin—polycystic ovary syndrome	0.00103	0.0125	CcSEcCtD
Lamivudine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00102	0.0124	CcSEcCtD
Lamivudine—Muscle spasms—Metformin—polycystic ovary syndrome	0.001	0.0122	CcSEcCtD
Lamivudine—ABCC1—endometrium—polycystic ovary syndrome	0.000988	0.00684	CbGeAlD
Lamivudine—ABCC3—endocrine gland—polycystic ovary syndrome	0.000984	0.00682	CbGeAlD
Lamivudine—Tremor—Metformin—polycystic ovary syndrome	0.000977	0.0119	CcSEcCtD
Lamivudine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000967	0.0118	CcSEcCtD
Lamivudine—SLC22A3—adrenal gland—polycystic ovary syndrome	0.000966	0.00669	CbGeAlD
Lamivudine—Malaise—Metformin—polycystic ovary syndrome	0.00094	0.0114	CcSEcCtD
Lamivudine—SLC22A1—vagina—polycystic ovary syndrome	0.000936	0.00649	CbGeAlD
Lamivudine—ABCC4—adrenal gland—polycystic ovary syndrome	0.000936	0.00649	CbGeAlD
Lamivudine—Syncope—Metformin—polycystic ovary syndrome	0.000935	0.0114	CcSEcCtD
Lamivudine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000916	0.0112	CcSEcCtD
Lamivudine—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000916	0.00634	CbGeAlD
Lamivudine—ABCC1—uterus—polycystic ovary syndrome	0.00091	0.00631	CbGeAlD
Lamivudine—ABCC2—adrenal gland—polycystic ovary syndrome	0.000906	0.00628	CbGeAlD
Lamivudine—SLC22A3—female gonad—polycystic ovary syndrome	0.0009	0.00624	CbGeAlD
Lamivudine—SLC22A3—vagina—polycystic ovary syndrome	0.000895	0.0062	CbGeAlD
Lamivudine—ABCC1—pituitary gland—polycystic ovary syndrome	0.000894	0.00619	CbGeAlD
Lamivudine—ABCC1—adipose tissue—polycystic ovary syndrome	0.00089	0.00617	CbGeAlD
Lamivudine—Myalgia—Metformin—polycystic ovary syndrome	0.000887	0.0108	CcSEcCtD
Lamivudine—Chest pain—Metformin—polycystic ovary syndrome	0.000887	0.0108	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000881	0.0107	CcSEcCtD
Lamivudine—Discomfort—Metformin—polycystic ovary syndrome	0.000877	0.0107	CcSEcCtD
Lamivudine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000876	0.00607	CbGeAlD
Lamivudine—ABCC4—female gonad—polycystic ovary syndrome	0.000873	0.00605	CbGeAlD
Lamivudine—Oedema—Metformin—polycystic ovary syndrome	0.000851	0.0104	CcSEcCtD
Lamivudine—Infection—Metformin—polycystic ovary syndrome	0.000845	0.0103	CcSEcCtD
Lamivudine—SLC22A3—endocrine gland—polycystic ovary syndrome	0.000837	0.0058	CbGeAlD
Lamivudine—Shock—Metformin—polycystic ovary syndrome	0.000837	0.0102	CcSEcCtD
Lamivudine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000834	0.0102	CcSEcCtD
Lamivudine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000833	0.0101	CcSEcCtD
Lamivudine—Skin disorder—Metformin—polycystic ovary syndrome	0.000826	0.0101	CcSEcCtD
Lamivudine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000822	0.01	CcSEcCtD
Lamivudine—ABCG2—endometrium—polycystic ovary syndrome	0.000818	0.00566	CbGeAlD
Lamivudine—ABCC4—endocrine gland—polycystic ovary syndrome	0.000812	0.00563	CbGeAlD
Lamivudine—Anorexia—Metformin—polycystic ovary syndrome	0.000811	0.00988	CcSEcCtD
Lamivudine—ABCC1—adrenal gland—polycystic ovary syndrome	0.000798	0.00553	CbGeAlD
Lamivudine—Hypotension—Metformin—polycystic ovary syndrome	0.000795	0.00968	CcSEcCtD
Lamivudine—ABCC2—endocrine gland—polycystic ovary syndrome	0.000786	0.00545	CbGeAlD
Lamivudine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000775	0.00944	CcSEcCtD
Lamivudine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000764	0.0093	CcSEcCtD
Lamivudine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000758	0.00924	CcSEcCtD
Lamivudine—Somnolence—Metformin—polycystic ovary syndrome	0.000756	0.00921	CcSEcCtD
Lamivudine—ABCG2—uterus—polycystic ovary syndrome	0.000753	0.00522	CbGeAlD
Lamivudine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000749	0.00912	CcSEcCtD
Lamivudine—ABCC1—female gonad—polycystic ovary syndrome	0.000744	0.00516	CbGeAlD
Lamivudine—ABCC1—vagina—polycystic ovary syndrome	0.00074	0.00513	CbGeAlD
Lamivudine—ABCG2—pituitary gland—polycystic ovary syndrome	0.00074	0.00513	CbGeAlD
Lamivudine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00074	0.00901	CcSEcCtD
Lamivudine—ABCG2—adipose tissue—polycystic ovary syndrome	0.000737	0.00511	CbGeAlD
Lamivudine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000734	0.00895	CcSEcCtD
Lamivudine—Fatigue—Metformin—polycystic ovary syndrome	0.000733	0.00893	CcSEcCtD
Lamivudine—Constipation—Metformin—polycystic ovary syndrome	0.000728	0.00886	CcSEcCtD
Lamivudine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000701	0.00854	CcSEcCtD
Lamivudine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000696	0.00847	CcSEcCtD
Lamivudine—Urticaria—Metformin—polycystic ovary syndrome	0.000676	0.00823	CcSEcCtD
Lamivudine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000673	0.00819	CcSEcCtD
Lamivudine—ABCG2—adrenal gland—polycystic ovary syndrome	0.000661	0.00458	CbGeAlD
Lamivudine—ABCG2—female gonad—polycystic ovary syndrome	0.000616	0.00427	CbGeAlD
Lamivudine—ABCG2—vagina—polycystic ovary syndrome	0.000613	0.00424	CbGeAlD
Lamivudine—Asthenia—Metformin—polycystic ovary syndrome	0.00061	0.00743	CcSEcCtD
Lamivudine—Pruritus—Metformin—polycystic ovary syndrome	0.000602	0.00733	CcSEcCtD
Lamivudine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000582	0.00709	CcSEcCtD
Lamivudine—Dizziness—Metformin—polycystic ovary syndrome	0.000563	0.00685	CcSEcCtD
Lamivudine—ABCB1—embryo—polycystic ovary syndrome	0.000551	0.00382	CbGeAlD
Lamivudine—Vomiting—Metformin—polycystic ovary syndrome	0.000541	0.00659	CcSEcCtD
Lamivudine—Rash—Metformin—polycystic ovary syndrome	0.000536	0.00653	CcSEcCtD
Lamivudine—Dermatitis—Metformin—polycystic ovary syndrome	0.000536	0.00653	CcSEcCtD
Lamivudine—Headache—Metformin—polycystic ovary syndrome	0.000533	0.00649	CcSEcCtD
Lamivudine—Nausea—Metformin—polycystic ovary syndrome	0.000505	0.00616	CcSEcCtD
Lamivudine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000452	0.00313	CbGeAlD
Lamivudine—ABCB1—endometrium—polycystic ovary syndrome	0.000403	0.00279	CbGeAlD
Lamivudine—ABCB1—uterus—polycystic ovary syndrome	0.000372	0.00257	CbGeAlD
Lamivudine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000365	0.00253	CbGeAlD
Lamivudine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000363	0.00252	CbGeAlD
Lamivudine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000326	0.00226	CbGeAlD
Lamivudine—ABCB1—female gonad—polycystic ovary syndrome	0.000304	0.00211	CbGeAlD
Lamivudine—ABCB1—vagina—polycystic ovary syndrome	0.000302	0.00209	CbGeAlD
Lamivudine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000283	0.00196	CbGeAlD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.43e-05	0.000233	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	4.42e-05	0.000233	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	4.42e-05	0.000233	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.42e-05	0.000233	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HMMR—polycystic ovary syndrome	4.39e-05	0.000231	CbGpPWpGaD
Lamivudine—NME1—Metabolism—MTHFR—polycystic ovary syndrome	4.38e-05	0.00023	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TH—polycystic ovary syndrome	4.37e-05	0.00023	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HSD3B2—polycystic ovary syndrome	4.34e-05	0.000229	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	4.33e-05	0.000228	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.31e-05	0.000227	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.27e-05	0.000225	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	4.25e-05	0.000224	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.22e-05	0.000222	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKR1C1—polycystic ovary syndrome	4.21e-05	0.000221	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.2e-05	0.000221	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.17e-05	0.00022	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.15e-05	0.000219	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—STAR—polycystic ovary syndrome	4.13e-05	0.000217	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.13e-05	0.000217	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	4.11e-05	0.000216	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—LHB—polycystic ovary syndrome	4.08e-05	0.000215	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.08e-05	0.000215	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	4.02e-05	0.000211	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	3.99e-05	0.00021	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HSD3B2—polycystic ovary syndrome	3.99e-05	0.00021	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.97e-05	0.000209	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.97e-05	0.000209	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	3.94e-05	0.000207	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.94e-05	0.000207	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.93e-05	0.000207	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SULT2A1—polycystic ovary syndrome	3.87e-05	0.000204	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKR1C1—polycystic ovary syndrome	3.87e-05	0.000203	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	3.85e-05	0.000203	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	3.81e-05	0.0002	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.77e-05	0.000198	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—RRM2—polycystic ovary syndrome	3.75e-05	0.000197	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	3.7e-05	0.000195	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	3.68e-05	0.000194	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.66e-05	0.000193	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STAR—polycystic ovary syndrome	3.63e-05	0.000191	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.63e-05	0.000191	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	3.62e-05	0.00019	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.62e-05	0.00019	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—YAP1—polycystic ovary syndrome	3.61e-05	0.00019	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	3.59e-05	0.000189	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.59e-05	0.000189	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	3.58e-05	0.000189	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNAS—polycystic ovary syndrome	3.57e-05	0.000188	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SULT2A1—polycystic ovary syndrome	3.56e-05	0.000187	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	3.56e-05	0.000187	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PPARG—polycystic ovary syndrome	3.55e-05	0.000187	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	3.51e-05	0.000185	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	3.51e-05	0.000185	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.5e-05	0.000184	CbGpPWpGaD
Lamivudine—NME1—Metabolism—POMC—polycystic ovary syndrome	3.5e-05	0.000184	CbGpPWpGaD
Lamivudine—NME1—Metabolism—INS—polycystic ovary syndrome	3.48e-05	0.000183	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NAMPT—polycystic ovary syndrome	3.47e-05	0.000183	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.47e-05	0.000183	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.46e-05	0.000182	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—RRM2—polycystic ovary syndrome	3.45e-05	0.000181	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP11A1—polycystic ovary syndrome	3.43e-05	0.00018	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	3.4e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF18—polycystic ovary syndrome	3.36e-05	0.000177	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	3.35e-05	0.000176	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.35e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RBP4—polycystic ovary syndrome	3.33e-05	0.000175	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—YAP1—polycystic ovary syndrome	3.32e-05	0.000175	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.29e-05	0.000173	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.28e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.28e-05	0.000172	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKR1C3—polycystic ovary syndrome	3.24e-05	0.00017	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	3.24e-05	0.00017	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	3.22e-05	0.000169	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	3.2e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LHB—polycystic ovary syndrome	3.2e-05	0.000168	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NAMPT—polycystic ovary syndrome	3.19e-05	0.000168	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP17A1—polycystic ovary syndrome	3.19e-05	0.000168	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.17e-05	0.000167	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP11A1—polycystic ovary syndrome	3.15e-05	0.000166	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.13e-05	0.000165	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	3.13e-05	0.000165	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IGF1—polycystic ovary syndrome	3.11e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT2—polycystic ovary syndrome	3.11e-05	0.000163	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	3.09e-05	0.000162	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GAB1—polycystic ovary syndrome	3.06e-05	0.000161	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.06e-05	0.000161	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	3.05e-05	0.00016	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.05e-05	0.00016	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	3.03e-05	0.000159	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.01e-05	0.000159	CbGpPWpGaD
Lamivudine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	3e-05	0.000158	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	2.99e-05	0.000157	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NAMPT—polycystic ovary syndrome	2.99e-05	0.000157	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKR1C3—polycystic ovary syndrome	2.98e-05	0.000157	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	2.95e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP17A1—polycystic ovary syndrome	2.93e-05	0.000154	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.85e-05	0.00015	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—polycystic ovary syndrome	2.82e-05	0.000148	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LHB—polycystic ovary syndrome	2.82e-05	0.000148	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.81e-05	0.000148	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	2.79e-05	0.000147	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	2.79e-05	0.000147	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	2.78e-05	0.000147	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TH—polycystic ovary syndrome	2.76e-05	0.000145	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	2.75e-05	0.000145	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	2.74e-05	0.000144	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.72e-05	0.000143	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	2.7e-05	0.000142	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.69e-05	0.000141	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A4—polycystic ovary syndrome	2.68e-05	0.000141	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	2.67e-05	0.00014	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.64e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	2.6e-05	0.000137	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	2.6e-05	0.000137	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.59e-05	0.000136	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.59e-05	0.000136	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.54e-05	0.000134	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TH—polycystic ovary syndrome	2.53e-05	0.000133	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP19A1—polycystic ovary syndrome	2.52e-05	0.000133	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	2.5e-05	0.000132	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.49e-05	0.000131	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	2.47e-05	0.00013	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A4—polycystic ovary syndrome	2.47e-05	0.00013	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.46e-05	0.000129	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	2.45e-05	0.000129	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.45e-05	0.000129	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—polycystic ovary syndrome	2.43e-05	0.000128	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.43e-05	0.000128	CbGpPWpGaD
Lamivudine—DCK—Metabolism—POMC—polycystic ovary syndrome	2.4e-05	0.000126	CbGpPWpGaD
Lamivudine—DCK—Metabolism—INS—polycystic ovary syndrome	2.39e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	2.38e-05	0.000125	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	2.35e-05	0.000124	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	2.35e-05	0.000123	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.34e-05	0.000123	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	2.33e-05	0.000123	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP19A1—polycystic ovary syndrome	2.32e-05	0.000122	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.31e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	2.31e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	2.3e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	2.29e-05	0.000121	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	2.27e-05	0.000119	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.26e-05	0.000119	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNAS—polycystic ovary syndrome	2.25e-05	0.000118	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRL—polycystic ovary syndrome	2.2e-05	0.000116	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	2.2e-05	0.000116	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	2.19e-05	0.000115	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	2.18e-05	0.000115	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	2.17e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.17e-05	0.000114	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.15e-05	0.000113	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.15e-05	0.000113	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NCOR1—polycystic ovary syndrome	2.14e-05	0.000113	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	2.11e-05	0.000111	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNAS—polycystic ovary syndrome	2.07e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.06e-05	0.000108	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	2.05e-05	0.000108	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A1—polycystic ovary syndrome	2.03e-05	0.000107	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.03e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	2.03e-05	0.000107	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	2.03e-05	0.000107	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	2.02e-05	0.000106	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	2e-05	0.000105	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	2e-05	0.000105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TH—polycystic ovary syndrome	1.99e-05	0.000105	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NCOR1—polycystic ovary syndrome	1.97e-05	0.000104	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.96e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.96e-05	0.000103	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	1.93e-05	0.000102	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—polycystic ovary syndrome	1.9e-05	9.97e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.89e-05	9.96e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—polycystic ovary syndrome	1.87e-05	9.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.86e-05	9.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NCOR1—polycystic ovary syndrome	1.84e-05	9.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	1.82e-05	9.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRG1—polycystic ovary syndrome	1.81e-05	9.53e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.75e-05	9.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.75e-05	9.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.75e-05	9.2e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—polycystic ovary syndrome	1.74e-05	9.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	1.73e-05	9.1e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.7e-05	8.95e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.68e-05	8.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.67e-05	8.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.65e-05	8.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—polycystic ovary syndrome	1.63e-05	8.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	1.62e-05	8.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	1.61e-05	8.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.6e-05	8.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.58e-05	8.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.57e-05	8.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS2—polycystic ovary syndrome	1.55e-05	8.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	1.54e-05	8.13e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—polycystic ovary syndrome	1.54e-05	8.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.52e-05	8.01e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POMC—polycystic ovary syndrome	1.52e-05	7.98e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—INS—polycystic ovary syndrome	1.51e-05	7.93e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.49e-05	7.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.47e-05	7.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1.46e-05	7.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.44e-05	7.58e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	1.43e-05	7.51e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	1.41e-05	7.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	1.41e-05	7.43e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POMC—polycystic ovary syndrome	1.39e-05	7.33e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—INS—polycystic ovary syndrome	1.39e-05	7.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	1.37e-05	7.18e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.36e-05	7.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS1—polycystic ovary syndrome	1.35e-05	7.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	1.35e-05	7.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.33e-05	6.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	1.32e-05	6.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—INS—polycystic ovary syndrome	1.3e-05	6.82e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.29e-05	6.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.28e-05	6.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.28e-05	6.71e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	1.25e-05	6.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT2—polycystic ovary syndrome	1.25e-05	6.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.24e-05	6.52e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.2e-05	6.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	1.19e-05	6.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.19e-05	6.26e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	1.19e-05	6.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.19e-05	6.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.17e-05	6.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.11e-05	5.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1.11e-05	5.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	1.11e-05	5.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	5.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POMC—polycystic ovary syndrome	1.09e-05	5.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—INS—polycystic ovary syndrome	1.09e-05	5.71e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	9.74e-06	5.13e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	9.64e-06	5.07e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POMC—polycystic ovary syndrome	9.61e-06	5.06e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—INS—polycystic ovary syndrome	9.55e-06	5.03e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	9.51e-06	5e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	9.45e-06	4.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TH—polycystic ovary syndrome	9.45e-06	4.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	9.19e-06	4.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	8.98e-06	4.73e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	8.86e-06	4.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	8.81e-06	4.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.64e-06	4.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.71e-06	4.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	7.35e-06	3.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.97e-06	3.67e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.49e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—polycystic ovary syndrome	5.66e-06	2.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.27e-06	2.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.19e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.16e-06	2.72e-05	CbGpPWpGaD
